Search Results - "Canu, L"

Management and outcome of metastatic pheochromocytomas/paragangliomas: an overview by De Filpo, G., Maggi, M., Mannelli, M., Canu, L.

“…Background Metastatic pheochromocytomas and paragangliomas (PPGLs) occur in about 5–26% of cases and are characterized by a heterogeneous prognosis. Metastases…”
Get full text

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study by Elhassan, Y S, Altieri, B, Berhane, S, Cosentini, D, Calabrese, A, Haissaguerre, M, Kastelan, D, Fragoso, M C B V, Bertherat, J, Al Ghuzlan, A, Haak, H, Boudina, M, Canu, L, Loli, P, Sherlock, M, Kimpel, O, Laganà, M, Sitch, A J, Kroiss, M, Arlt, W, Terzolo, M, Berruti, A, Deeks, J J, Libé, R, Fassnacht, M, Ronchi, C L

“…Objective Adrenocortical carcinoma (ACC) has an aggressive but variable clinical course. Prognostic stratification based on the European Network for the Study…”
Get full text

Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience by De Filpo, G., Cantini, G., Rastrelli, G., Vannini, G., Ercolino, T., Luconi, M., Mannelli, M., Maggi, M., Canu, L.

“…Background Pheochromocytoma (PHEO) and paraganglioma (PGL) are rare neuroendocrine tumors releasing catecholamines. Metastatic pheochromocytomas/paragangliomas…”
Get full text

Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment by Fei, L., Cantini, G., Nocentini, A., Nardini, P., Catarinicchia, S., Canu, L., Ercolino, T., Quartararo, G., Nesi, G., Gacci, M., Maggi, M., Hantel, C., Mannelli, M., Supuran, C. T., Luconi, M.

“…Purpose Adrenocortical carcinoma (ACC), a rare malignancy of the adrenocortex, is characterized by a crosstalk between the adipose microenvironment and tumor…”
Get full text

Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis by Armignacco, R., Cantini, G., Canu, L., Poli, G., Ercolino, T., Mannelli, M., Luconi, M.

“…Over the last decade, the development of novel and high penetrance genomic approaches to analyze biological samples has provided very new insights in the…”
Get full text

Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN) by van Haalen, F M, Kaya, M, Pelsma, I C M, Dekkers, O M, Biermasz, N R, Cannegieter, S C, Huisman, M V, van Vlijmen, B J M, Feelders, R A, Klok, F A, Pereira, A M

“…Cushing's syndrome (CS) is associated with an hypercoagulable state and an increased risk of venous thromboembolism (VTE). Evidence-based guidelines on…”
Get full text

Does antithrombotic prophylaxis worsen early outcomes of total thyroidectomy? - a retrospective cohort study by Erdas, E, Medas, F, Sanna, S, Gordini, L, Pisano, G, Canu, G L, Calò, P G

“…Currently, there is no strong evidence on the effectiveness and safety of pharmacological antithrombotic prophylaxis in thyroid surgery. The aim of this study…”
Get full text

Volumetric evaluation of CT images of adrenal glands in primary aldosteronism by Velema, M. S., Canu, L., Dekkers, T., Hermus, A. R. M. M., Timmers, H. J. L. M., Schultze Kool, L. J., Groenewoud, H. J. M. M., Jacobs, C., Deinum, J.

“…Objectives To investigate whether adrenal volumetry provides better agreement with adrenal vein sampling (AVS) than conventional CT for subtyping PA…”
Get full text

Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey by Cherenko, M, Appelman-Dijkstra, N M, Priego Zurita, A L, Biermasz, N R, Dekkers, O M, Klok, F A, Reisch, N, Aulinas, A, Biagetti, B, Cannavo, S, Canu, L, Detomas, M, Devuyst, F, Falhammar, H, Feelders, R A, Ferrau, F, Gatto, F, Grasselli, C, van Houten, P, Hoybye, C, Isidori, A M, Kyrilli, A, Loli, P, Maiter, D, Nowak, E, Pivonello, R, Ragnarsson, O, Steenaard, R V, Unger, N, van de Ven, A, Webb, S M, Yeste, D, Ahmed, S F, Pereira, A M

“…Patients with Cushing syndrome (CS) are at increased risk of venous thromboembolism (VTE). The aim was to evaluate the current management of new cases of CS…”
Get full text

Primary thyroid leiomyosarcoma: a case report and review of the literature by Canu, G L, Bulla, J S, Lai, M L, Medas, F, Baghino, G, Erdas, E, Mariotti, S, Calò, P G

“…Primary thyroid leiomyosarcoma (LMS) is an extremely rare tumor. We report a case of a 47-year-old male with a rapidly growing neck mass and disfagia…”
Get full text

Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE) by Stigliano, A, Chiodini, I, Giordano, R, Faggiano, A, Canu, L, Della Casa, S, Loli, P, Luconi, M, Mantero, F, Terzolo, M

Get full text

Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma by Laganà, M., Grisanti, S., Ambrosini, R., Cosentini, D., Abate, A., Zamparini, M., Ferrari, V.D., Gianoncelli, A., Turla, A., Canu, L., Terzolo, M., Tiberio, G.A.M., Sigala, S., Berruti, A.

“…Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with a poor prognosis. No efficacious treatment options are currently available for patients…”
Get full text

Mitochondrial function and content in pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers by Rapizzi, E, Ercolino, T, Canu, L, Giaché, V, Francalanci, M, Pratesi, C, Valeri, A, Mannelli, M

“…To date, the consequences of succinate dehydrogenase (SDH) impairment on overall mitochondrial functions are still obscure. In this study, we evaluated SDH…”
Get full text

[OP.3A.06] LONG TERM FOLLOW-UP IN PATIENTS OPERATED ON A PHEOCHROMOCYTOMA OR A PARAGANGLIOMA: COMPILATION OF THE ENS@T DATABASE by Amar, L, Deutschbein, T, Piscaer, I, Brugger, C, Canu, L, Bertherat, J, Lepoutre, C, Dekkers, O, Stell, A, Gimenez-roqueplo, A, Fassnacht, M, Robledo, M, Mannelli, M, Lenders, J, Timmers, H, Beuschlein, F, Curras-freixes, M, Plouin, P.-F, Steichen, O

“…OBJECTIVE:Following resection of the primary tumor, patients with pheochromocytoma or paragangliomas (PPGL) are at risk of tumor persistence or tumor…”
Get full text

What is the Real Incidence of Trocar Site Hernias? by Erdas, Enrico, Canu, Gian L., Cappellacci, Federico, Medas, Fabio, Calò, Pietro G.

Get full text

Tentacle-shaped mesh for fixation-free repair of umbilical hernias by Amato, G., Romano, G., Agrusa, A., Canu, G. L., Gulotta, E., Erdas, E., Calò, P. G.

“…Purpose Mesh fixation and broad overlap represent an open issue in umbilical hernia repair. A proprietary-designed implant with tentacle straps at its boundary…”
Get full text

Pseudoangiomatous stromal hyperplasia (PASH) presenting as axillary lump: case report and review of the literature by Canu, G L, Medas, F, Ravarino, A, Furcas, S, Loi, G, Cerrone, G, Rossi, C, Erdas, E, Calò, P G

“…Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon benign mesenchymal breast lesion. There are extremely rare reports of PASH arising in accessory…”
Get full text

PO-0826: Hypofractionated radiotherapyfor HNSCC: a retrospective analysis of single Institution by Sanna, F., Cabras, F., Carai, A., Marogna, S., Musu, A., Orefici, E., Piredda, G., Pittau, P., Sini, C., Urpis, M., Pelagatti, L., Santona, M.C., Giobbe, M., Bandinu, L., Cau, S., Canu, L., Salis, F., Dei, S., Capelli, F., Campoccia, S.

Get full text

PO-0801: Hypofractionated radiotherapy for HNSCC: a retrospective analysis of single Institution by Sanna, F., Cabras, F., Carai, A., Marogna, S., Musu, A.R., Orefici, E., Piredda, G., Pittau, P., Sini, C., Urpis, M., Pelagatti, L., Santona, M.C., Giobbe, M., Bandinu, L., Cau, S., Canu, L., Salis, F., Dei, S., Capelli, F., Campoccia, S.

Get full text

Kikuchi-Fujimoto disease with lateral neck localisation: a case report by Biggio, A, Lai, A, Demontis, G, Cossu, S, Canu, L, Proto, E

“…The case is described of a Kikuchi-Fujimoto disease, in a 22-year-old female, onset of which was characterised by rapidly evolving lateral neck…”
Get full text